MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Clinical trials for MALIGNANT GENITOURINARY SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT GENITOURINARY SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT GENITOURINARY SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for immunotherapy side effects: which drug works best?
Disease control OngoingThis study compares two medications, infliximab and vedolizumab, for treating colitis (colon inflammation) caused by immune checkpoint inhibitor therapy in cancer patients. About 47 adults with genitourinary cancer, melanoma, or non-small cell lung cancer will receive one of thes…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
New drug cocktail shows promise for Hard-to-Treat urinary cancers
Disease control OngoingThis early-phase trial tests the safety and best dose of a combination of two or three drugs (cabozantinib, nivolumab, and possibly ipilimumab) in people with advanced genitourinary cancers that have spread. About 152 adults with these cancers will participate. The goal is to fin…
Matched conditions: MALIGNANT GENITOURINARY SYSTEM NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:48 UTC